Successful Transition from Subcutaneous Immune Globulin (SCIG) Therapy to Intravenous Immune Globulin (IVIG) Therapy in Primary Immunodeficiency: A Case Report
Infusion Journal · 2023
DOI: 10.70776/oekv1454 ↗Kurz gefasst
Fallbericht in der Zeitschrift Infusion Journal, 2023. Verfasst von Amy Mulgrew und 2 weiteren Autor:innen.
Abstract (Originalsprache)
For patients with primary immunodeficiency (PI), immune globulin (Ig) is a lifelong therapy. This specialized infusion therapy is a safe and practical option for patients to receive in the comfort of their own homes. Intravenous immune globulin (IVIG) and subcutaneous immune globulin (SCIG) are clinically proven effective treatments for PI and offer distinct advantages and disadvantages for each route of administration. Using patient characteristics to help guide decisions for intravenous or subcutaneous treatment, Ig therapy must be individualized to meet each patient’s specific clinical needs with consideration for patient preferences. The following patient case report describes a successful transition from SCIG to IVIG therapy, emphasizing the importance of patient choice and individualization of treatment. Keywords: chronic variable immunodeficiency, subcutaneous immune globulin, intravenous immune globulin
Zitieren
APA
Mulgrew, A., McKenna, A., & Mullis, E. (2023). Successful Transition from Subcutaneous Immune Globulin (SCIG) Therapy to Intravenous Immune Globulin (IVIG) Therapy in Primary Immunodeficiency: A Case Report. Infusion Journal. https://doi.org/10.70776/oekv1454
Vancouver
Mulgrew A, McKenna A, Mullis E. Successful Transition from Subcutaneous Immune Globulin (SCIG) Therapy to Intravenous Immune Globulin (IVIG) Therapy in Primary Immunodeficiency: A Case Report. Infusion Journal. 2023. doi:10.70776/oekv1454
BibTeX
@article{Mulgrew2023,
author = {Mulgrew, Amy and McKenna, Ashley and Mullis, Erin},
title = {Successful Transition from Subcutaneous Immune Globulin (SCIG) Therapy to Intravenous Immune Globulin (IVIG) Therapy in Primary Immunodeficiency: A Case Report},
journal = {Infusion Journal},
year = {2023},
doi = {10.70776/oekv1454}
}
EUVIMED